276 filings
8-K
BAX
Baxter International Inc.
9 May 24
Departure of Directors or Certain Officers
4:27pm
8-K
BAX
Baxter International Inc.
2 May 24
Baxter Reports First-quarter 2024 Results
7:17am
8-K
BAX
Baxter International Inc.
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
8-K
BAX
Baxter International Inc.
4 Mar 24
Regulation FD Disclosure
8:30am
8-K
BAX
Baxter International Inc.
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
pbq ei1f25g
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
72l760
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
0phnz
2 Oct 23
Completion of Acquisition or Disposition of Assets
9:02am
8-K
p3upegnhhpgi7g ybz
21 Aug 23
Baxter Announces Updates to Its Board of Directors
5:03pm
8-K
r1s9967r6i
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
mtv3 ksrt
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
2krmy 02q30zu
29 Jun 23
Baxter Appoints William Ampofo to Its Board
4:18pm
8-K
n0jrbms0ng
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
0cxtly 2hqo
4 May 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
hfz623ri4
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
540x1dwlg7ukbx
13 Mar 23
Entry into a Material Definitive Agreement
4:45pm
8-K
sgaml5n0qpl7l
14 Feb 23
Departure of Directors or Certain Officers
4:35pm
8-K
kgh9dqwz
9 Feb 23
Baxter Reports Fourth-quarter and Full-year 2022 Results
7:18am
8-K
hegf3cc q9
6 Jan 23
Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders
7:03am
8-K
b0e7m krna8j
27 Oct 22
Baxter Reports Third-quarter 2022 Results
7:18am